AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,410 | -66.4% | 25,018 | -68.9% | 0.00% | -66.7% |
| Q2 2023 | $3,761,533 | +66783.6% | 80,564 | +54705.4% | 0.01% | – |
| Q1 2023 | $5,624 | -99.9% | 147 | -99.9% | 0.00% | -100.0% |
| Q4 2022 | $6,829,614 | +341380.7% | 124,628 | +226496.4% | 0.02% | – |
| Q3 2022 | $2,000 | -75.0% | 55 | -93.1% | 0.00% | – |
| Q2 2022 | $8,000 | -94.0% | 800 | -91.5% | 0.00% | – |
| Q1 2022 | $133,000 | -89.6% | 9,400 | -78.6% | 0.00% | -100.0% |
| Q1 2021 | $1,273,000 | +63550.0% | 43,885 | +66392.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -96.4% | 66 | -97.0% | 0.00% | – |
| Q2 2020 | $55,000 | -24.7% | 2,204 | -35.9% | 0.00% | -100.0% |
| Q1 2020 | $73,000 | – | 3,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |